AstraZeneca Korea denies collaboration with Zuellig Korea

Published: 2003-03-20 06:57:00

Updated: 2003-03-20 06:57:00

Wholesaling business sources say that unlike MSD Korea's moving to Zuellig Korea during next month, AstraZeneca Korea's outsourcing towards Zuellig Korea is now said to be groundless.

An official from AstraZeneca Korea said, "As things stand, we have no business plan with Zuellig Korea, a mul...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK